Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4430-4437, Vol. 69, No. 7
Department of Veterinary Science and
Microbiology, The University of Arizona, Tucson, Arizona 85721
Received 21 February 2001/Returned for modification 13 April
2001/Accepted 23 April 2001
Arcanobacterium pyogenes is an opportunistic
pathogen, associated with suppurative infections in domestic animals.
In addition to pyolysin, a pore-forming, cholesterol-binding toxin,
A. pyogenes expresses a number of putative virulence
factors, including several proteases and neuraminidase activity. A
3,009-bp gene, nanH, was cloned and sequenced and
conferred neuraminidase activity on an Escherichia coli
host strain. The predicted 107-kDa NanH protein displayed similarity to
a number of bacterial neuraminidases and contained the RIP/RLP motif
and five copies of the Asp box motif found in all bacterial
neuraminidases. Recombinant His-tagged NanH was found to have pH and
temperature optima of 5.5 to 6.0 and 55°C, respectively. Insertional
deletion of the nanH gene resulted in the reduction, but
not absence, of neuraminidase activity, indicating the presence of a
second neuraminidase gene in A. pyogenes. NanH was
localized to the A. pyogenes cell wall. A.
pyogenes adhered to HeLa, CHO, and MDBK cells in a
washing-resistant manner. However, the nanH mutant was
not defective for adherence to epithelial cells. The role of NanH in
host epithelial cell adherence may be masked by the presence of a
second neuraminidase in A. pyogenes.
Arcanobacterium
pyogenes is a common inhabitant of the upper respiratory,
urogenital (12, 54), and gastrointestinal tracts (35; B. H. Jost, K. W. Post, and S. J. Billington, unpublished data) of many domestic animal species. However,
a physical or microbial insult to the host can lead to a variety of
suppurative A. pyogenes infections, such as mastitis in
dairy cows (27) and goats (2), liver
abscesses in feedlot cattle (31, 34), and pneumonia in
pigs (26) and various species of wildlife (17, 42,
57). A. pyogenes can also infect avian species
(10) and humans (5, 16, 19), although
infections in humans are rare.
A. pyogenes elaborates a number of extracellular proteins,
including the hemolytic exotoxin pyolysin (PLO) (8),
several proteases (48, 51), a DNase (30), and
at least one neuraminidase (47). While all these proteins
are putative virulence factors, only for PLO is there definitive
evidence of involvement in the pathogenesis of infections by A. pyogenes (29).
Recently, there has been interest in the neuraminidases of
bacterial pathogens and the potential role they play in pathogenesis. Neuraminidase (N-acetylneuraminyl hydrolase; EC 3.2.1.18)
removes sialic acid from glycolipids, glycoproteins, and poly- and
oligosaccharides. Bacterial neuraminidases have only 20 to 30% amino
acid sequence identity, but they contain two conserved motifs, the
RIP/RLP motif (Arg-Ile/Leu-Pro) and the Asp box motif
(Ser-X-Asp-X-Gly-X-Thr-Trp), which occurs four or five times in the
enzyme (14, 21, 43).
Neuraminidases are virulence factors, especially in bacteria that
inhabit mucosal surfaces (20, 22, 52, 55), and they may
play several roles in virulence. This enzyme can make sialic acid
available as a carbon source to promote growth in a nutrient-limited environment (11, 23). The action of neuraminidase can
decrease mucus viscosity (24), possibly enhancing
colonization of the underlying tissues. Desialylation by neuraminidases
can increase the susceptibility of mucosal IgA to bacterial proteases
(18, 41). Neuraminidase can enhance bacterial adhesion and
colonization (9, 13, 22, 56) and susceptibility of the
host to the action of toxins (20), by exposing cryptic
host cell receptor molecules.
This paper describes the cloning and characterization of a
neuraminidase expressed by A. pyogenes. In addition, we show
that A. pyogenes can adhere to epithelial cells in a
washing-resistant manner, and we have investigated whether
neuraminidase plays a role in this adhesion.
Bacteria and growth conditions.
A. pyogenes
strain BBR1 was isolated from a bovine abscess. Other A. pyogenes strains used in this study were from veterinary diagnostic laboratories or personal collections. A. pyogenes
strains were grown on brain heart infusion (BHI; Difco) agar plates,
supplemented with 5% bovine blood, at 37°C and 5%
CO2 or in BHI broth supplemented with 5% bovine
calf serum at 37°C with shaking. Escherichia coli DH5 Preparation of CSF, CWE, and protoplasts.
Culture
supernatant fluid (CSF) was prepared from liquid cultures of A. pyogenes grown overnight to an optical density at 600 nm
(OD600) of approximately 3.0 to 4.0. Cells were
removed by centrifugation at 5,000 × g, and the CSF
was filtered through a 0.22-µm-pore-size filter. A. pyogenes cell wall extract (CWE) and protoplasts were prepared as
previously described for Streptococcus pneumoniae
(36). Protoplasts were resuspended in distilled water and
were lysed by several cycles of freezing and thawing. Total protein
concentration was determined using the Bradford protein assay reagent
(Bio-Rad).
DNA techniques.
Preparation of plasmid DNA and
electroporation-mediated transformation of A. pyogenes
strains were performed as previously described (28).
Genomic DNA from A. pyogenes was isolated by the method of
Pospiech and Neumann (40). A library of A. pyogenes BBR1 genomic DNA was constructed in Nucleotide sequence determination.
The sequence of
nanH was determined from plasmids pJGS274 and pJGS292 and
appropriate subclones using automated DNA sequencing. Sequencing was
performed on both strands, crossing all restriction sites, using KS,
SK, or T7 sequencing primers or oligonucleotide primers based on
the sequence of nanH. Oligonucleotide primers were
synthesized by Sigma-Genosys. Sequencing reactions were performed by
the DNA Sequencing Facility at The University of Arizona, using a 377 DNA sequencer (Applied Biosystems Inc.).
Computer sequence analysis.
Nucleotide sequence data were
compiled using the Sequencher program (GeneCodes). Database searches
were performed using the BlastX and BlastP algorithms (3).
Sequence analysis was performed using the suite of programs available
through the Genetics Computer Group, Inc. (University of Wisconsin).
Signal sequence prediction was performed using SignalP
(38). Multiple sequence alignments were performed using
CLUSTAL W (53).
Cloning and purification of a recombinant, six-His-tagged NanH
(His-NanH).
The nanH gene, lacking the coding region
for the signal sequence, was amplified from A. pyogenes BBR1
genomic DNA by PCR with a 5' primer containing an NheI site
(5'-GGTTGCAGCTAGCGCCCCGAGCACAG-3') and a 3'
primer containing a PstI site
(5'-GCGTTATCGCGCTGCAGATTTAGCCC-3') (restriction
sites are underlined). These primers amplified a 2.9-kb product
from bases 120 to 3009 of the plo gene. The PCR fragment was
digested with NheI-PstI and cloned into
NheI-PstI-digested pTrcHis B (Invitrogen) to
generate pJGS306. pJGS306 encoded His-NanH, a 977-amino-acid protein
comprising 963 amino acids of the mature NanH with an N-terminal
extension of 14 amino acids encoded by pTrcHis B, including a six-His sequence.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4430-4437.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cloning, Expression, and Characterization of a
Neuraminidase Gene from Arcanobacterium
pyogenes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MCR strains (Gibco-BRL) were grown at 37°C on Luria-Bertani (LB; Difco) agar or in LB broth with shaking. Antibiotics (Sigma) were
added as appropriate; for A. pyogenes strains, erythromycin (EM) at 15 µg/ml and kanamycin (KM) at 30 µg/ml; for E. coli strains, ampicillin at 100 µg/ml, chloramphenicol at 30 µg/ml, EM at 200 µg/ml, and KM at 50 µg/ml.
GEM-12, according
to the manufacturer's instructions (Promega). Methods for growth and purification of bacteriophage were essentially as described by Ausubel
et al. (4). DNA was prepared from bacteriophage as previously described (46) and was further purified using
the Wizard DNA clean-up system (Promega). E. coli plasmid
DNA extraction, transformation, DNA restriction, ligation, agarose gel
electrophoresis, and Southern transfer of DNA to nitrocellulose
membranes were performed essentially as described elsewhere
(4). Preparation of DNA probes, DNA hybridization, and
probe detection were performed using a digoxigenin DNA labeling
and detection kit (Roche), as recommended by the manufacturer. PCR DNA
amplification was performed using Taq DNA polymerase (Fisher
Scientific) with the supplied reaction buffer for 35 cycles consisting
of 1 min at 94°C, 1 min at 55°C, and 1 min/kb at 72°C, with a
final extension step of 72°C for 5 min.
-D-thiogalactopyranoside (IPTG; Gold
Biotechnology) for 3 h. Cells were harvested by centrifugation at
5,000 × g, and the cell pellet was resuspended in 20 mM Tris-HCl-100 mM NaCl, pH 8.0. The cells were disrupted by two
passages through a French pressure cell (Aminco) at 138 MPa, and the
insoluble material was removed by centrifugation at 12,000 × g. His-NanH was purified from the soluble fraction using
TALON metal affinity resin (Clontech), per the manufacturer's
instructions. His-NanH was eluted from the resin with 50 mM
imidazole-20 mM Tris-HCl-100 mM NaCl, pH 8.0 (TALON elution buffer).
Total protein concentration was determined using the Bradford protein
assay reagent (Bio-Rad).
Preparation of goat antiserum to His-NanH. A female goat was immunized with 500 µg of His-NanH in a Ribi adjuvant system (Corexa) intramuscularly in the hind leg at two sites. A similar booster immunization of 500 µg of His-NanH in RAS was administered on days 29, 43, and 64. Blood was collected on day 75, and serum was harvested from the clotted blood by centrifugation at 400 × g. Preimmune serum was prepared in a similar manner, prior to immunization.
SDS-polyacrylamide gel electrophoresis (PAGE) and Western
blotting.
E. coli whole cells or purified His-NanH was
mixed 1:1 with sodium dodecyl sulfate (SDS) sample buffer (0.2 M
Tris-HCl [pH 6.8], 2.5% SDS, 10%
-mercaptoethanol, 20%
glycerol, 0.013% bromophenol blue) and boiled for 10 min prior to
electrophoresis in a 10% (wt/vol) SDS-polyacrylamide gel, essentially
as described previously (4). Proteins were transferred to
nitrocellulose (Schleicher and Schuell), and Western blots were
immunostained as previously described (4) using goat
anti-His-NanH and rabbit anti-goat immunoglobulin G (heavy plus light
chains)-peroxidase conjugate (Kirkegaard & Perry Laboratories)
as the primary and secondary antibodies, respectively. When required,
sera were absorbed overnight at 4°C with an equal volume of bacterial
cells which had been previously disrupted by two passages through a
French pressure cell (Aminco) at 138 MPa. The sera were sterilized by
passage through a 0.22-µm-pore-size filter prior to use.
Neuraminidase activity assay.
Neuraminidase activity was
assayed using the fluorogenic substrate
2'-(4-methylumbelliferyl)-
-D-N-acetylneuraminic
acid (MUAN) (Sigma) (33), essentially as described by
Winter et al. (60). One unit was defined as the release of
1 µmol of 4-methylumbelliferone from MUAN per min at 37°C.
Epithelial cell adhesion assay. The epithelial cell lines used in the adherence experiments were Chinese hamster ovary (CHO) cells, human cervical epithelial cells (HeLa), and Madin-Darby bovine kidney (MDBK) cells. All cell lines were cultured in Iscove's modified Dulbecco's medium (Life Technologies) supplemented with 10% fetal bovine serum (Omega Scientific) (IMDM-10%) with 100 µg of gentamicin/ml (Sigma) in a humidified, 5% CO2 atmosphere at 37°C. For adherence assays, epithelial cells in IMDM-10% without gentamicin were seeded into 24-well plates at 2 × 105 cells per well in 1-ml volumes. The cells were incubated at 37°C and 5% CO2 for 18 h prior to addition of bacteria (freshly grown to an OD600 of 1.0) and His-NanH, where applicable. The plates were centrifuged for 10 min at 400 × g to increase the bacterium-host cell contact. Bacterial adhesion was assessed after 1 h of incubation at 37°C and 5% CO2. Cell monolayers were washed three times with 0.01 M phosphate-buffered saline, pH 7.2 (PBS), to remove nonadherent bacteria. Bacteria were recovered by treatment of the cell monolayers with 1 ml of 0.1% Triton X-100 for 10 min at 0°C, and viable bacteria were enumerated by dilution plating. All experiments were performed in triplicate on three separate occasions.
Nucleotide sequence accession number. The nanH sequence data were submitted to the DDBJ/EMBL/GenBank databases under accession number AF298154.
| |
RESULTS |
|---|
|
|
|---|
A. pyogenes strains express neuraminidase activity. A total of 53 strains of A. pyogenes isolated from a variety of animals, including bovine, porcine, and avian species were tested for neuraminidase expression by the filter paper method. All 53 strains were positive for neuraminidase activity, indicating that this enzyme is probably expressed by all A. pyogenes isolates.
In addition, neuraminidase activity was expressed throughout the cell cycle. A. pyogenes BBR1 cells, grown to an OD600 of 0.45, 1.0, or 5.2, were washed once with PBS, and an equal number of cells was applied to filter paper saturated with MUAN. All the samples fluoresced strongly, indicating that at least in vitro, neuraminidase activity was present throughout the A. pyogenes cell cycle.Cloning and nucleotide sequence determination of
nanH.
During a project to clone A. pyogenes promoter sequences in the promoter-probe vector pKK232-8
(Amersham Pharmacia Biotech), sequences homologous to the neuraminidase
gene, nedA, of Micromonospora viridifaciens (45) were identified. In order
to clone the entire gene, a probe was prepared from a region spanning
bases 1639 to 1898 of the nanH gene and was used to probe a
GEM-12 library of BBR1 genomic DNA. Several plaques hybridized
strongly with the probe and were selected for further analysis. One of
these,
JGS6, contained an approximately 16-kb partial
Sau3AI fragment. DNA purified from
JGS6 was digested with
BamHI or HindIII and cloned into similarly
digested pBC KS (Stratagene). Two overlapping clones encompassing the
entire nanH gene region were obtained: pJGS274, containing a
3,773-bp BamHI fragment, and pJGS292, containing a 6,151-bp
HindIII fragment (Fig. 1).
pJGS274, but not pJGS292, conferred neuraminidase activity on the
E. coli host, as determined by the MUAN filter paper assay.
|
G =
17.0 kcal/mol) was identified 26 bases
downstream of the nanH stop codon. No E. coli
70-like promoter sequences were apparent
upstream of the nanH gene.
Upstream of nanH, an open reading frame (ORF),
birA, was identified, and its protein product had similarity
to biotin ligase from Deinococcus radiodurans
(59). Downstream sequences contained ORFs whose protein
products had similarity to the electron transport proteins, FixABCX,
involved in nitrogen fixation in Bradyrhizobium japonicum
(25, 58). birA and the putative
fixABCX operon were also transcribed in the opposite
direction to nanH (Fig. 1), suggesting that nanH
is monocistronic.
Analysis of the primary structure of NanH.
Cleavage at the
predicted signal peptide sequence of NanH would result in a mature
protein with a predicted molecular mass of 103.2 kDa and a pI of 6.3. NanH showed similarity to a number of bacterial neuraminidases,
including those from Actinomyces viscosus (31.2% identity,
61.8% similarity), M. viridifaciens (21.4% identity,
42.3% similarity), and Bacteroides fragilis (13.7% identity, 33.4% similarity). In addition, the NanH protein contained the conserved catalytic RIP/RLP motif, as well as five copies of the
Asp box motif (Ser-X-Asp-X-Gly-X-Thr-Trp) associated with bacterial
neuraminidases (14, 21, 43) (Fig.
2).
|
Cloning and expression of His-NanH.
To facilitate the
purification of recombinant NanH from E. coli, the
NanH-coding sequence, lacking the sequence for the putative signal
peptide was cloned into pTrcHis B. SDS-PAGE and Coomassie brilliant blue staining of IPTG-induced cultures of DH5
MCR(pJGS306) did not reliably indicate the presence of an overexpressed protein of
approximately 104 kDa, compared to similarly induced cultures of
DH5
MCR(pTrcHis B) (Fig. 3A). However,
His-NanH was purified from DH5
MCR(pJGS306) to >90% homogeneity
using TALON resin (Fig. 3A), and the size of this protein corresponded
to that of the predicted molecular mass of His-NanH. His-NanH routinely
purified as a doublet, which may indicate some processing of the
protein in E. coli (Fig. 3A). Purified His-NanH retained
neuraminidase activity as determined using the fluorometric assay with
MUAN as a substrate.
|
Reaction of His-NanH with specific antibodies.
In Western
blots, antiserum prepared against His-NanH detected a protein of
approximately 104 kDa in IPTG-induced cultures of DH5
MCR(pJGS306)
and preparations of purified His-NanH but not IPTG-induced cultures of
DH5
MCR(pTrcHis B) (Fig. 3C). Preimmune serum also weakly reacted
with His-NanH (Fig. 3B). This is not surprising, as A. pyogenes is a common inhabitant of the bacterial flora in domestic
animals, and sera from normal goats contain antibodies to NanH and
other A. pyogenes proteins, such as PLO (8;
B. H. Jost and S. J. Billington, unpublished data).
Determination of optimal conditions for enzyme activity. In order to determine the pH optimum for this enzyme, the activity of 25 ng of His-NanH was measured by the fluorometric assay using MUAN as a substrate in 100 mM citrate-phosphate buffer with a pH ranging from 3.0 to 8.5. The pH optimum for His-NanH was 5.5 to 6.0 (data not shown). Similarly, the temperature optimum for His-NanH was determined by incubation with MUAN in 100 mM citrate-phosphate buffer, pH 6.0, at temperatures ranging from 23 to 75°C. The temperature optimum for His-NanH was 55°C (data not shown). The enzyme was quite robust, with approximately 45% of the maximal activity after 1 h at 75°C. Because His-NanH had >90% of maximal activity at 37°C and 37°C is a physiologically relevant temperature, 37°C was chosen as the standard incubation temperature. Purified His-NanH had a specific activity of 1.3 U/mg at pH 6.0 and 37°C.
Previous reports have suggested that the large bacterial neuraminidases require Ca2+ ions for activity (14). The requirement for divalent cations was tested by incubation of 25 ng of His-NanH in 100 mM citrate-phosphate buffer, pH 6.0, for 1 h at 37°C with final concentrations of 1 mM CaCl2, 1 mM MgCl2, or 10 mM EDTA. Addition or removal of divalent cations did not significantly affect the activity of His-NanH (data not shown).Determination of the prevalence of the nanH gene by DNA dot blotting. In order to determine whether nanH was present in all A. pyogenes strains, genomic DNA was prepared from 53 A. pyogenes strains and was subjected to hybridization at high stringency with a nanH-specific probe that spanned bases 1639 to 1898 of the nanH ORF. The DNA from all 53 strains hybridized strongly to the probe (data not shown), indicating that the nanH gene is present in all A. pyogenes strains.
Construction and characterization of a nanH
mutant.
Construction of the nanH mutant used an allelic
exchange plasmid in which the nanH gene was completely
replaced by an erm(X) cassette (Fig.
4). This plasmid was constructed by
deletion of the 2.6-kb ClaI fragment containing the
nanH gene sequences from pJGS292 (Fig. 1), resulting in the
recombinant plasmid pJGS326. The 0.73-kb ClaI fragment of
pJGS293, containing sequences upstream of nanH, was cloned
into similarly digested pJGS326 to form pJGS354. The entire 4.3-kb
HindIII insert of pJGS342 was cloned into similarly digested pHSS20 (37) to form pJGS356. The KM resistance
gene in pHSS20 is functional in A. pyogenes and was used to
identify the presence of recombinants which arose by a single crossover event. A 1.65-kb HindIII-BamHI fragment
containing the erm(X) gene from pNG2 (50) was
treated with T4 DNA polymerase (Promega). This fragment was cloned into
the similarly treated unique ClaI site in pJGS356 to
generate the recombinant plasmid pJGS357 (Fig. 4). As pJGS357 was based
on a ColE1 replicon, it acted as a suicide plasmid in A. pyogenes (29). pJGS357 plasmid DNA was introduced into A. pyogenes BBR1 cells by electroporation, and
recombinants were selected on BHI-blood agar containing EM.
Emr Kms colonies were
chosen for further analysis.
|
|
Localization of NanH. Whole cells, CSF, and CWE were prepared from BBR1 and NANH-1 which had been grown overnight to an OD600 of 3.0 to 4.0. These samples were tested for neuraminidase activity with the fluorometric assay using MUAN as a substrate. The majority of neuraminidase activity was detected in whole cells and CWE from either BBR1 or NANH-1. However, BBR1 whole cells and CWE had significantly higher neuraminidase activity than whole cells and CWE from NANH-1 (Fig. 5). Some neuraminidase activity was detected in the CSF of both BBR1 and NANH-1 (Fig. 5), and this activity may have resulted from fragments of cell wall material present in the CSF. Negligible neuraminidase activity was detected in lysed protoplasts of BBR1 and NANH-1 (Fig. 5). These data indicate that the majority of NanH-specific neuraminidase activity was associated with the cell wall. In addition, the activity of the putative second neuraminidase also appeared to be cell wall associated.
Adherence of A. pyogenes to epithelial cells.
It was previously demonstrated that A. pyogenes adhered to
HeLa cells (15). We also tested the ability of BBR1 to
adhere to other epithelial cell lines. BBR1 adhered to CHO, HeLa, and MDBK cells in a washing-resistant manner (Fig.
6A). However, bacterial adherence was
greatest using HeLa cells (Fig. 6A), and this cell line was used in all
subsequent studies.
|
| |
DISCUSSION |
|---|
|
|
|---|
This is the first report of the cloning and sequencing of a neuraminidase gene, nanH, from A. pyogenes. In addition, this work provides indirect evidence that A. pyogenes expresses a second neuraminidase. NanH was localized to the cell wall, and the second neuraminidase also appeared to be cell wall associated. Furthermore, we demonstrated that neuraminidase activity is expressed by all A. pyogenes strains tested (n = 53).
The nanH gene of A. pyogenes was cloned and sequenced and appeared to exist in a monocistronic operon, surrounded by the housekeeping genes birA and fixABCX. nanH expressed a 103.2-kDa protein with neuraminidase activity, and the NanH protein was most closely related to the neuraminidase of A. viscosus (61). The NanH protein contained sequences consistent with its activity as a neuraminidase, including the RIP/RLP motif and five copies of the Asp box (14, 21, 43). In addition, the finding that NanH is localized to the A. pyogenes cell wall is consistent with the presence of an N-terminal signal peptide and C-terminal cell sorting signals, including an LPXTG-like cell anchor (49). However, in NanH, the cell wall anchor motif is LVHTG, which is slightly at variance with the consensus sequence observed in almost all cell wall-associated proteins identified to date. One exception is a sucrase expressed by Actinomyces naeslundii, which has the motif LARTG (39). In addition, two other cell wall-associated proteins have been identified in A. pyogenes, both of which have cell sorting signals where the Pro of the LPXTG motif has been replaced (B. H. Jost and S. J. Billington, unpublished data). Therefore, it appears that the A. pyogenes cell anchor sequence may be divergent from those seen in other bacteria.
Recombinant His-NanH protein was found to have optimal activity at pH 5.5 to 6.0 and 55°C, with no requirement for Ca2+ or Mg2+. These conditions correspond to those previously reported for a purified, native A. pyogenes neuraminidase (47). However, there were differences in the apparent size and cellular location of NanH (103.2 kDa, cell wall) and the purified, native A. pyogenes neuraminidase (50 kDa, CSF) (47). Size variation, probably as a result of specific breakdown or proteolytic cleavage, has been observed in other bacterial neuraminidases, with the truncated proteins retaining enzymatic activity. The 107-kDa S. pneumoniae NanA is observed as an enzymatically active 86-kDa species following purification (32). The size of the M. viridifaciens NedA protein varies between 41 and 68 kDa depending on the culture conditions (45). Indeed, upon prolonged storage at 4°C, His-NanH converted to a species of 62 kDa, with no loss of specific activity (data not shown). However, it is still uncertain whether NanH is the 50-kDa neuraminidase purified from A. pyogenes CSF (47). NanH was localized to the cell wall of A. pyogenes, but NanH was also present in CSF, as NANH-1 had significantly less neuraminidase activity in the CSF than BBR1 (Fig. 5). Schaufuss and Lämmler could detect significant neuraminidase activity in the CSF of only 2 out of 42 of A. pyogenes strains tested, and they did not report testing whole cells or CWE for the presence of neuraminidase activity (47).
The entire nanH ORF was deleted during the construction of NANH-1, as confirmed by Southern blotting (data not shown). Significant neuraminidase activity in NANH-1 indicated the presence of a second enzyme in A. pyogenes. In addition, the location of the second neuraminidase also appeared to be cell wall associated, as evidenced by the retention of some neuraminidase activity in the CWE of NANH-1.
The initial event in infection by many bacteria is their attachment to mammalian cells via specific recognition structures, leading to bacterial colonization of the host. Adherence of A. naeslundii to both a human epithelial cell line (9) and polymorphonuclear leukocytes (44) was enhanced by pretreatment with neuraminidase. Like A. pyogenes, S. pneumoniae expresses two distinct neuraminidases, NanA (7), which is cell associated, and NanB (6), which is thought to be secreted from the cell. Neuraminidase treatment of tracheal organ cultures increased the adherence of S. pneumoniae (56). Furthermore, S. pneumoniae mutants deficient in neuraminidase activity had reduced abilities to colonize and persist in the nasopharynx (55).
It is clear that neuraminidase activity plays a role in mediating host cell adhesion of some pathogens to mucosal surfaces. In order to determine whether this was the case for A. pyogenes, experiments assessing the adhesion of NANH-1, the neuraminidase mutant, were conducted. As previously reported, A. pyogenes can adhere to HeLa cells (15), and we demonstrated adherence to other epithelial cell lines, although A. pyogenes adhered best to HeLa cells. NANH-1 displayed no defect in adherence to HeLa cells compared with the wild-type, BBR1. If the neuraminidase activity does play a role in mediating adherence of A. pyogenes, it is possible that, at least under these conditions, the second neuraminidase was sufficient for maximal adherence. If this is the case, addition of exogenous His-NanH would not significantly affect adhesion to the host cell. Alternately, neuraminidase may play no role in the adhesion of A. pyogenes to cultured epithelial cells. The effects of neuraminidase activity may be more evident in vivo, where it may act to reduce mucus viscosity (24), assisting the adherence of A. pyogenes by other colonization factors, such as putative collagen- or fibronectin-binding proteins. The validity of these hypotheses is being tested in our laboratory by construction of a knockout mutant of the second neuraminidase in NANH-1 and assessment of the ability of this double mutant to adhere to host epithelial cells, both in vitro and in vivo.
| |
ACKNOWLEDGMENTS |
|---|
We thank Stefani Gilbert for construction of the
GEM-12
library and Hien Trinh and Dawn Bueschel for their excellent technical assistance.
Partial support for this work was provided by USDA/NRICGP awards (97-35204-4750 and 99-35204-7818).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Veterinary Science and Microbiology, The University of Arizona, 1117 East Lowell St., Tucson, AZ 85721. Phone: (520) 621 2745. Fax: (520) 621 6366. E-mail: jost{at}u.arizona.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akimoto, S., T. Ono, H. Tsutsui, T. Kinouchi, K. Kataoka, and Y. Ohnishi. 1994. Complete sequence of the Bacteroides fragilis YCH46 neuraminidase-encoding gene. Biochem. Biophys. Res. Commun. 203:914-921[CrossRef][Medline]. |
| 2. | Al-Graibawi, M. A. A., V. K. Sharma, and A. J. Al-Shammari. 1986. Microbial pathogens from goat mastitis and phage-typing of Staphylococcus aureus isolates. Comp. Immunol. Microbiol. Infect. Dis. 9:23-28[CrossRef][Medline]. |
| 3. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[CrossRef][Medline]. |
| 4. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology, vol. 1. Greene Publishing Associates and John Wiley and Sons, Inc., New York, N.Y. |
| 5. | Barnham, M. 1988. Actinomyces pyogenes bacteraemia in a patient with carcinoma of the colon. J. Infect. 27:231-234. |
| 6. |
Berry, A. M.,
R. A. Lock, and J. C. Paton.
1996.
Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli.
J. Bacteriol.
178:4854-4860 |
| 7. | Berry, A. M., J. C. Paton, E. M. Glare, D. Hansman, and D. E. A. Catcheside. 1988. Cloning and expression of the pneumococcal neuraminidase gene in Escherichia coli. Gene 71:299-305[CrossRef][Medline]. |
| 8. |
Billington, S. J.,
B. H. Jost,
W. A. Cuevas,
K. R. Bright, and J. G. Songer.
1997.
The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family.
J. Bacteriol.
179:6100-6106 |
| 9. |
Brennan, M. J.,
J. O. Cisar,
A. E. Vatter, and A. L. Sandberg.
1984.
Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.
Infect. Immun.
46:459-464 |
| 10. | Brinton, M. K., L. C. Schellberg, J. B. Johnson, R. K. Frank, D. A. Halvorson, and J. A. Newman. 1993. Description of osteomyelitis lesions associated with Actinomyces pyogenes infection in the proximal tibia of adult male turkeys. Avian Dis. 37:259-262[CrossRef][Medline]. |
| 11. | Byers, H. L., K. A. Homer, and D. Beighton. 1997. Sialic acid utilisation by viridans streptococci. Adv. Exp. Med. Biol. 418:713-716[Medline]. |
| 12. | Carter, G. R., and M. M. Chengappa. 1991. Essentials of veterinary bacteriology and mycology, 4th ed. Lea and Febiger, Philadelphia, Pa. |
| 13. | Childs, W. C., and R. J. Gibbons. 1990. Selective modulation of bacterial attachment to oral epithelial cells by enzyme activities associated with poor oral hygiene. J. Periodontal Res. 25:172-178[CrossRef][Medline]. |
| 14. | Crennell, S. J., E. F. Garman, C. Philippon, A. Vasella, W. G. Laver, E. R. Vimr, and G. L. Taylor. 1996. The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. J. Mol. Biol. 259:264-280[CrossRef][Medline]. |
| 15. | Ding, H., C. Lämmler, and R. S. Selim. 1993. Adherence of Actinomyces pyogenes to HeLa cells mediated by hydrophobic surface proteins. Zentralbl. Bakteriol. 279:299-306[Medline]. |
| 16. | Drancourt, M., O. Oulès, V. Bouche, and Y. Peloux. 1993. Two cases of Actinomyces pyogenes infection in humans. Eur. J. Clin. Microbiol. Infect. Dis. 12:55-57[CrossRef][Medline]. |
| 17. | Foreyt, W. J., and D. A. Jessup. 1982. Fatal pneumonia of bighorn sheep following association with domestic sheep. J. Wildl. Dis. 18:163-168[Abstract]. |
| 18. | Frandsen, E. V. G. 1994. Carbohydrate depletion of immunoglobulin A1 by oral species of gram-positive rods. Oral Microbiol. Immunol. 9:352-358[Medline]. |
| 19. | Gahrn-Hansen, B., and W. Frederiksen. 1992. Human infections with Actinomyces pyogenes (Corynebacterium pyogenes). Diagn. Microbiol. Infect. Dis. 15:349-354[CrossRef][Medline]. |
| 20. |
Galen, J. E.,
J. M. Ketley,
A. Fasano,
S. H. Richardson,
S. S. Wasserman, and J. B. Kaper.
1992.
Role of Vibrio cholerae neuraminidase in the function of cholera toxin.
Infect. Immun.
60:406-415 |
| 21. |
Gaskell, A.,
S. Crennell, and G. Taylor.
1995.
The three domains of a bacterial sialidase: a -propeller, an immunoglobulin module and a galactose-binding jelly-roll.
Structure
3:1197-1205[Medline].
|
| 22. | Giebink, G. S. 1999. Otitis media: the chinchilla model. Microb. Drug Resist. 5:57-72[Medline]. |
| 23. |
Godoy, V. G.,
M. Miller Dallas,
T. A. Russo, and M. H. Malamy.
1993.
A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems.
Infect. Immun.
61:4415-4426 |
| 24. | Gottschalk, A. 1960. Correlation between composition, structure, shape, and function of a salivary mucoprotein. Nature 186:949-951[CrossRef][Medline]. |
| 25. | Gubler, M., T. Zurcher, and H. Hennecke. 1989. The Bradyrhizobium japonicum fixBCX operon: identification of fixX and of a 5' mRNA region affecting the level of the fixBCX transcript. Mol. Microbiol. 3:141-148[CrossRef][Medline]. |
| 26. | Høie, S., K. Falk, and B. M. Lium. 1991. An abattoir survey of pneumonia and pleuritis in slaughter weight swine from 9 selected herds. IV. Bacteriological findings in chronic pneumonic lesions. Acta Vet. Scand. 32:395-402[Medline]. |
| 27. | Jonsson, P., S.-E. Olsson, A.-S. Olofson, C. Fälth, O. Holmberg, and H. Funke. 1991. Bacteriological investigations of clinical mastitis in heifers in Sweden. J. Dairy Res. 58:179-185[Medline]. |
| 28. | Jost, B. H., S. J. Billington, and J. G. Songer. 1997. Electroporation-mediated transformation of Arcanobacterium (Actinomyces) pyogenes. Plasmid 38:135-140[CrossRef][Medline]. |
| 29. |
Jost, B. H.,
J. G. Songer, and S. J. Billington.
1999.
An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.
Infect. Immun.
67:1723-1728 |
| 30. | Lämmler, C. 1990. Untersuchungen zu möglichen Pathogenitätsfaktoren von Actinomyces pyogenes Übersichtsreferat. Berl. Muench. Tieraerztl. Wochenschr. 103:121-125. |
| 31. | Lechtenberg, K. F., T. G. Nagaraja, H. W. Leipold, and M. M. Chengappa. 1988. Bacteriologic and histologic studies of hepatic abscesses in cattle. Am. J. Vet. Res. 49:58-62[Medline]. |
| 32. | Lock, R. A., J. C. Paton, and D. Hansman. 1988. Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniae. Microb. Pathog. 4:33-43[CrossRef][Medline]. |
| 33. |
Myers, R. W.,
R. T. Lee,
Y. C. Lee,
G. H. Thomas,
L. W. Reynolds, and Y. Uchida.
1980.
The synthesis of 4-methylumbelliferyl -ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase.
Anal. Biochem.
101:166-174[CrossRef][Medline].
|
| 34. | Nagaraja, T. G., S. B. Laudert, and J. C. Parrott. 1996. Liver abscesses in feedlot cattle. Part I. Causes, pathogenesis, pathology, and diagnosis. Comp. Cont. Educ. Pract. Vet. 18:S230-S241, S256. |
| 35. | Narayanan, S., T. G. Nagaraja, N. Wallace, J. Staats, M. M. Chengappa, and R. D. Oberst. 1998. Biochemical and ribotypic comparison of Actinomyces pyogenes and A. pyogenes-like organisms from liver abscesses, ruminal wall, and ruminal contents of cattle. Am. J. Vet. Res. 59:271-276[Medline]. |
| 36. |
Neeleman, C.,
S. P. M. Geelen,
P. C. Aerts,
M. R. Daha,
T. E. Mollnes,
J. J. Roord,
G. Posthuma,
H. van Dijk, and A. Fleer.
1999.
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.
Infect. Immun.
67:4517-4524 |
| 37. | Nickoloff, J. A., and R. J. Reynolds. 1991. Subcloning with new ampicillin- and kanamycin-resistant analogs of pUC19. BioTechniques 10:469-472[Medline]. |
| 38. |
Nielsen, H.,
J. Engelbrecht,
S. Brunak, and G. von Heijne.
1997.
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.
Prot. Eng.
10:1-6 |
| 39. | Norman, J. M., K. L. Bunny, and P. M. Giffard. 1995. Characterization of levJ, a sucrase/fructanase-encoding gene from Actinomyces naeslundii T14V, and comparison of its product with other sucrose-cleaving enzymes. Gene 152:93-98[CrossRef][Medline]. |
| 40. | Pospiech, A., and B. Neumann. 1995. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet. 11:217-218[CrossRef][Medline]. |
| 41. |
Reinholdt, J.,
M. Tomana,
S. B. Mortensen, and M. Kilian.
1990.
Molecular aspects of immunoglobulin A1 degradation by oral streptococci.
Infect. Immun.
58:1186-1194 |
| 42. | Rhyan, J. C., K. Aune, D. R. Ewalt, J. Marquardt, J. W. Mertins, J. B. Payeur, D. A. Saari, P. Schladweiler, E. J. Sheehan, and D. Worley. 1997. Survey of free-ranging elk from Wyoming and Montana for selected pathogens. J. Wildlife Dis. 33:290-298[Abstract]. |
| 43. | Roggentin, P., B. Rothe, J. B. Kaper, J. Galen, L. Lawrisuk, E. C. Vimr, and R. Schauer. 1989. Conserved sequences in bacterial and viral sialidases. Glycoconjugate J. 6:349-353[CrossRef][Medline]. |
| 44. |
Ruhl, S.,
J. O. Cisar, and A. L. Sandberg.
2000.
Identification of polymorphonuclear leukocyte and HL-60 cell receptors for adhesins of Streptococcus gordonii and Actinomyces naeslundii.
Infect. Immun.
68:6346-6354 |
| 45. |
Sakurada, K.,
T. Ohta, and M. Hasegawa.
1992.
Cloning, expression and characterization of the Micromonospora viridifaciens neuraminidase gene in Streptomyces lividans.
J. Bacteriol.
174:6896-6903 |
| 46. |
Santos, M. A.
1991.
An improved method for the small scale preparation of bacteriophage DNA based on phage precipitation by zinc chloride.
Nucleic Acids Res.
19:5442 |
| 47. | Schaufuss, P., and C. Lämmler. 1989. Characterization of the extracellular neuraminidase produced by Actinomyces pyogenes. Zentralbl. Bakteriol. 271:28-35[Medline]. |
| 48. | Schaufuss, P., R. Sting, and C. Lämmler. 1989. Isolation and characterization of an extracellular protease of Actinomyces pyogenes. Zentralbl. Bakteriol. 271:452-459[Medline]. |
| 49. | Schneewind, O., D. Mihaylova-Petkov, and P. Model. 1993. Cell wall sorting signals in surface proteins of Gram-positive bacteria. EMBO J. 12:4083-4811[Medline]. |
| 50. |
Serwold-Davis, T. M., and N. B. Groman.
1986.
Mapping and cloning of Corynebacterium diphtheriae plasmid pNG2 and characterization of its relatedness to plasmids from skin coryneforms.
Antimicrob. Agents Chemother.
30:69-72 |
| 51. | Takeuchi, S., T. Kaidoh, and R. Azuma. 1995. Assay of proteases from Actinomyces pyogenes isolated from pigs and cows by zymography. J. Vet. Med. Sci. 57:977-979[Medline]. |
| 52. | Taylor, G. 1996. Sialidases: structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 6:830-837[CrossRef][Medline]. |
| 53. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 54. | Timoney, J. F., J. H. Gillespie, F. W. Scott, and J. E. Barlough. 1988. Hagan and Bruner's microbiology and infectious diseases of domestic animals, 8th ed. Cornell University Press, Ithaca, N.Y. |
| 55. |
Tong, H. H.,
L. E. Blue,
M. A. James, and T. F. DeMaria.
2000.
Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model.
Infect. Immun.
68:921-924 |
| 56. | Tong, H. H., M. A. McIver, L. M. Fisher, and T. F. DeMaria. 1999. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb. Pathog. 26:111-119[CrossRef][Medline]. |
| 57. |
Turnquist, S. E., and W. H. Fales.
1998.
Disseminated Actinomyces pyogenes infection in a free-ranging white-tailed deer.
J. Vet. Diagn. Investig.
10:86-89 |
| 58. | Weidenhaupt, M., P. Rossi, C. Beck, H. M. Fischer, and H. Hennecke. 1996. Bradyrhizobium japonicum possesses two discrete sets of electron transfer flavoprotein genes: fixA, fixB and etfS, etfL. Arch. Microbiol. 165:169-178[Medline]. |
| 59. |
White, O.,
J. A. Eisen,
J. F. Heidelberg,
E. K. Hickey,
J. D. Peterson,
R. J. Dodson,
D. H. Haft,
M. L. Gwinn,
W. C. Nelson,
D. L. Richardson,
K. S. Moffat,
H. Qin,
L. Jiang,
W. Pamphile,
M. Crosby,
M. Shen,
J. J. Vamathevan,
P. Lam,
L. McDonald,
T. Utterback,
C. Zalewski,
K. S. Makarova,
L. Aravind,
M. J. Daly,
K. W. Minton,
R. D. Fleischmann,
K. A. Ketchum,
K. E. Nelson,
S. Salzberg,
H. O. Smith,
J. C. Venter, and C. M. Fraser.
1999.
Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1.
Science
286:1571-1577 |
| 60. | Winter, A. J., S. D. Comis, M. P. Osborne, M. J. Tarlow, J. Stephen, P. W. Andrew, J. Hill, and T. J. Mitchell. 1997. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect. Immun. 65:4411-4418[Abstract]. |
| 61. |
Yeung, M.
1993.
Complete nucleotide sequencing of the Actinomyces viscosus T14V sialidase gene: presence of a conserved repeating sequence among strains of Actinomyces spp.
Infect. Immun.
61:109-116 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|